MDH2 and hepatocellular carcinoma: We employed a dichlorodihydrofluorescein diacetate (DCFH-DA) probe to monitor intracellular ROS levels and found that, compared with WT HCC cells, MDH2 knockdown cells significantly increased intracellular ROS levels upon RSL3 treatment (Figure 3A).